MetaCap

Rockwell Medical Inc. (RMTI)

NASDAQ: RMTIHealth CareBiotechnology: Pharmaceutical PreparationsUSD

5.82-0.44 (-7.03%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

RMTI stock chart

Technical analysis

Key statistics

All statistics
Market cap
$23.12M
EPS (TTM)
-$1.43
52-week range
4.89 – 12.90
Day range
5.82 – 6.29
Volume / Avg
51.38K / 25.91K
Beta
—

52-week range

$4.89$12.90

RMTI stock today

Shares of Rockwell Medical (RMTI) finished lower on Nov 20 at $5.82, a drop of 7.03% or $0.44 per share, versus the S&P 500's 3.70% decline. At this level, RMTI sits near the bottom of its 52-week range of $4.89 to $12.90: 54.9% below the high, set on Jan 20, 2026 and 19.0% above the low. RMTI is down 29.9% year to date, underperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has lost 34.6%.

Rockwell Medical has posted a net loss over the last twelve months (EPS of -$1.43), so its P/E ratio is not meaningful.

Summary generated from market data by MetaCap's automated system. Methodology

About Rockwell Medical

Company profile

Rockwell Medical, Inc., together with its subsidiaries, engages in the development, manufacture, commercialization, and distribution of various hemodialysis products for dialysis providers worldwide. It offers citrapure citric acid concentrate, dri-sate dry acid concentrate, renalpure liquid acid concentrate, dri-sate acid concentrate mixer, renalpure acid concentrate, renalpure bicarbonate concentrate, sterilyte bicarbonate concentrate, bicarbonate cartridges, and dry acid concentrate mixer, as well as ancillary products, including 5% acetic acid, cleaner, citric acid descaler, water softener salt pellets, and other supplies used by hemodialysis providers. The company's hemodialysis concentrate products are used to sustain patient's life by removing toxins and balancing electrolytes in a dialysis patient's bloodstream.

Industry
Biotechnology: Pharmaceutical Preparations
CEO
Dr. Mark Strobeck Ph.D.
Headquarters
Wixom, MI
Employees
157
IPO year
1998

Financial highlights

Full financials

In fiscal 2025, Rockwell Medical generated $69.3 million in revenue, down 31.8% from fiscal 2024, its first annual decline since 2021. Rockwell Medical reported a net loss of $5.3 million, compared with a loss of $480,000 a year earlier. Gross margin was 16.9% (down from 17.2%) and operating margin -6.8%.

Rockwell Medical annual revenue, net income and EPS
Fiscal yearFY 2025FY 2024FY 2023FY 2022FY 2021
Revenue$69.26M$101.49M$83.61M$72.81M$61.93M
Growth-31.76%+21.38%+14.84%+17.57%-0.43%
Net income$-5.31M$-480.00K$-8.44M$-18.68M$-32.67M
EPS (diluted)$-0.15$-0.03$-0.37$-1.31$-3.83

Analyst forecast

Forecast

Consensus (2 analysts)

none

Avg. price target

$20.00+243.64%

  • Strong buy 1
  • Buy 1
  • Hold 0
  • Sell 0
  • Strong sell 0

Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.

Earnings

Earnings history
Last reported (Sep/2026)
Nov 12, 2026
EPS actual vs est.
$-0.59 vs $-0.18
Surprise
-227.78%

RMTI news

All RMTI news

Rockwell Medical peers

Health Care sector
RMTI peer companies
CompanyPrice% ChgMarket capCompare
IMMPImmutep Limited ADR3.11-9.06%$22.92Mvs RMTI
IXHLIncannex Healthcare Inc.1.86+6.90%$23.34Mvs RMTI
ABVCABVC BioPharma Inc.0.8663-1.56%$23.37Mvs RMTI
SCYXSCYNEXIS Inc.2.38-8.64%$23.69Mvs RMTI
LITSLite Strategy Inc.0.8026-4.03%$23.99Mvs RMTI
CRVOCervoMed Inc.1.46+9.77%$22.09Mvs RMTI
AARDAardvark Therapeutics Inc.0.9226-7.74%$20.20Mvs RMTI
RNAZTransCode Therapeutics Inc.1.16-10.77%$20.07Mvs RMTI

Indexes, lists and sector

Rockwell Medical stock FAQ

What is Rockwell Medical's stock price today?

RMTI last traded at $5.82 as of Nov 20, 4:00 PM EST, down 7.03% on the day. Prices are delayed at least 15 minutes.

Does Rockwell Medical pay a dividend?

No. Rockwell Medical does not currently pay a regular cash dividend.

Who is Rockwell Medical's CEO?

Dr. Mark Strobeck Ph.D. is the chief executive officer of Rockwell Medical Inc., which has about 157 employees.

Has RMTI ever split its stock?

Yes. The most recent RMTI stock split was a 1-for-10 split on Jul 1, 2026, one of 2 splits on record.

What is the RMTI 52-week high?

The 52-week high for RMTI is $12.90 and the 52-week low is $4.89. The stock is currently 54.9% below its high.

Compare RMTI